{"id":"https://openalex.org/W4362480472","doi":"https://doi.org/10.1158/1940-6207.c.6547121","title":"Data from Dopamine Prevents Ultraviolet B\u2013induced Development and Progression of Premalignant Cutaneous Lesions through its D2 Receptors","display_name":"Data from Dopamine Prevents Ultraviolet B\u2013induced Development and Progression of Premalignant Cutaneous Lesions through its D2 Receptors","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362480472","doi":"https://doi.org/10.1158/1940-6207.c.6547121"},"language":"en","primary_location":{"id":"doi:10.1158/1940-6207.c.6547121","doi":"https://doi.org/10.1158/1940-6207.c.6547121","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1940-6207.c.6547121","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1940-6207.c.6547121","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101635100","display_name":"Kai L\u00fc","orcid":"https://orcid.org/0000-0002-4332-0042","observed_orcids":["https://orcid.org/0000-0002-4332-0042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034082652","display_name":"Madhavi Bhat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Madhavi Bhat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076748211","display_name":"Sara B. Peters","orcid":"https://orcid.org/0000-0001-7781-4799","observed_orcids":["https://orcid.org/0000-0001-7781-4799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Peters","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7781-4799","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110480595","display_name":"Rita Basu Mitra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita Mitra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015153331","display_name":"Xiaokui Molly Mo","orcid":"https://orcid.org/0000-0002-9797-2687","observed_orcids":["https://orcid.org/0000-0002-9797-2687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaokui Mo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007549562","display_name":"Tatiana M. Oberyszyn","orcid":"https://orcid.org/0000-0002-5308-0855","observed_orcids":["https://orcid.org/0000-0002-5308-0855"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatiana M. Oberyszyn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056511273","display_name":"Partha Dasgupta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Partha Sarathi Dasgupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Sujit Basu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sujit Basu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.7148000001907349,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.7148000001907349,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.19760000705718994,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.03869999945163727,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.7990000247955322},{"id":"https://openalex.org/keywords/uv-b-radiation","display_name":"UV-B radiation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/premalignant-skin-lesions","display_name":"premalignant skin lesions","score":0.9459999799728394},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.8809999823570251},{"id":"https://openalex.org/keywords/endothelial-cells","display_name":"endothelial cells","score":0.7260000109672546},{"id":"https://openalex.org/keywords/vegf-a","display_name":"VEGF-A","score":0.8849999904632568},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/skin-cancer-prevention","display_name":"skin cancer prevention","score":0.6200000047683716},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-agonist","display_name":"dopamine D2 receptor agonist","score":0.6179999709129333},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6331127882003784},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5687861442565918},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46691277623176575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42185020446777344},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40263617038726807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39128759503364563},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34618765115737915},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2885587215423584}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1940-6207.c.6547121","doi":"https://doi.org/10.1158/1940-6207.c.6547121","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1940-6207.c.6547121","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1940-6207.c.6547121","doi":"https://doi.org/10.1158/1940-6207.c.6547121","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1940-6207.c.6547121","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3154275287","https://openalex.org/W3187823763","https://openalex.org/W3122373999","https://openalex.org/W3166884577","https://openalex.org/W2032949354","https://openalex.org/W2123076324","https://openalex.org/W2019379237","https://openalex.org/W2182027481","https://openalex.org/W2001483019","https://openalex.org/W7065893675"],"abstract_inverted_index":{"Abstract":[0],"Although":[1],"the":[2,24,43,70,80,83,88,98,107,127,151,165],"role":[3,128],"of":[4,26,82,90,113,117,129,155,164],"dopamine":[5,130],"(DA)":[6],"in":[7,15,30,33,39,53,64,67,97,135],"malignant":[8,49],"tumors":[9],"has":[10],"been":[11],"reported,":[12],"its":[13,94,132,147],"function":[14],"premalignant":[16,119,138],"lesions":[17,38,142,157],"is":[18,106],"unknown.":[19],"Herein":[20],"we":[21],"report":[22,110],"that":[23,87],"stimulation":[25],"DA":[27,56,75,91,145],"D2":[28,57,76,95,133,148],"receptors":[29,96,134,149],"endothelial":[31,99],"cells":[32],"ultraviolet":[34],"B":[35],"(UVB)-induced":[36],"cutaneous":[37],"mice":[40,71],"significantly":[41],"reduced":[42],"tumor":[44,46],"number,":[45],"burden,":[47],"and":[48,66,115,131,143,153,158],"squamous":[50,139,161],"cell":[51,140,162],"carcinoma":[52,163],"these":[54,156],"animals.":[55],"receptor":[58,77],"agonist":[59],"inhibited":[60,79],"VEGFA-dependent":[61],"proangiogenic":[62],"genes":[63],"vitro":[65],"vivo.":[68],"However,":[69],"pretreated":[72],"with":[73],"selective":[74],"antagonist":[78],"actions":[81],"agonist,":[84],"thereby":[85],"suggesting":[86],"action":[89],"was":[92],"through":[93,146],"cells.":[100],"To":[101],"our":[102],"knowledge,":[103],"this":[104],"study":[105],"first":[108],"to":[109],"DA-mediated":[111],"regulation":[112],"pathogenesis":[114],"progression":[116,154],"UVB-induced":[118],"skin":[120,141],"lesions.":[121],"Prevention":[122],"Relevance:":[123],"This":[124],"investigation":[125],"demonstrates":[126],"UVB":[136],"induced":[137],"how":[144],"inhibits":[150],"development":[152],"subsequently":[159],"prevents":[160],"skin.":[166]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-05T00:00:00"}